Phase I-II Study of Advanced Head and Neck Squamous Cell Carcinoma Patients Treated With Recombinant Human Interferon Gamma
Authors:
- William M. KochWKWilliam M. Koch
- William P. McGuireWMWilliam P. McGuire
- Michael E. PooleMPMichael E. Poole
- Esther H. ChangECEsther H. Chang
- 1 November 1990
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Otolaryngology–Head & Neck Surgery
- Vol. 116 (11) , 1271-1277
Abstract
Research from JAMA Otolaryngology–Head & Neck Surgery — Phase I-II Study of Advanced Head and Neck Squamous Cell Carcinoma Patients Treated With Recombinant Human Interferon GammaKeywords
This publication has 12 references indexed in Scilit:
- Low-Dose Interferon Alfa-2b in the Treatment of Hairy Cell LeukemiaJNCI: Journal of the National Cancer Institute, 1989
- Lysis of Squamous Cell Carcinoma Via Antibody-Dependent Cellular CytotoxicityJAMA Otolaryngology–Head & Neck Surgery, 1989
- INDUCTION OF HLA-DR ANTIGEN ON HUMAN SQUAMOUS CARCINOMA BY RECOMBINANT INTERFERON GAMMAThe Laryngoscope, 1988
- Interferon Gamma Induced Oncolysis: An Effect on Head and Neck Squamous Carcinoma CulturesJAMA Otolaryngology–Head & Neck Surgery, 1988
- Adhesion of T lymphoblasts to epidermal keratinocytes is regulated by interferon gamma and is mediated by intercellular adhesion molecule 1 (ICAM-1).Journal of Experimental Medicine, 1988
- Phase I study of multiple dose intramuscularly administered recombinant gamma interferon.Journal of Clinical Oncology, 1986
- PHASE-I TRIAL OF RECOMBINANT INTERFERON GAMMA BY 1-HOUR IV INFUSION1986
- Phase I trial of recombinant interferon gamma in cancer patients.Journal of Clinical Oncology, 1986
- Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma.Journal of Experimental Medicine, 1984
- IMMUNOHISTOCHEMICAL ANALYSIS OF MALIGNANT MELANOMAS AND NEVOCELLULAR NEVI WITH MONOCLONAL-ANTIBODIES TO DISTINCT MONOMORPHIC DETERMINANTS OF HLA ANTIGENS1984